Loading...
Loading...
Analysts at Canaccord Genuity initiated coverage on shares of Radius Health
RDUS with a Buy rating.
The target price for Radius Health is set to $21.
Radius Health's shares dropped 2.57% to close at $12.14 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in